Content about Eli Lilly

May 16, 2011
Amylin accuses Lilly of anticompetitive activity in diabetes drug development, commercialization

Amylin Pharmaceuticals filed suit against Eli Lilly in federal court Monday concerning an agreement between the latter and German drug maker Boehringer Ingelheim to develop drugs for diabetes.

May 16, 2011
Lilly launches TruAssist

Drug maker Eli Lilly has launched what it’s calling an “umbrella” for its patient assistance programs.

May 16, 2011
Lilly to present cancer studies data at ASCO

Drug maker Eli Lilly will present data from more than 30 studies at the American Society of Clinical Oncology’s annual meeting in Chicago next month, the company said Monday.

May 5, 2011
Lilly invests $2.5 million into Grow What Works campaign

Eli Lilly announced its largest-ever education-focused grant.

April 28, 2011
Court upholds Lilly's patent for Cymbalta

Drug maker Eli Lilly will get at least two more years of patent exclusivity on a drug used to treat depression, anxiety and pain resulting from diabetic neuropathy and fibromyalgia, thanks to a court order issued Wednesday.

April 18, 2011
Lilly receives complete response letter for liprotamase

The Food and Drug Administration declined to approve a drug made by Eli Lilly for treating a disease of the pancreas that often occurs in patients with cystic fibrosis, Lilly said.

April 4, 2011
Lilly launches Axiron

A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.

March 18, 2011
Lilly issues warning over alcohol prep pads associated with Forteo

Drug maker Eli Lilly is warning patients to avoid using alcohol prep pads that come with one of its osteoporosis drugs due to the risk of bacterial infections.

March 10, 2011
Lilly names new VP oncology research

Eli Lilly on Thursday announced that it has named Greg Plowman VP oncology research and SVP for ImClone Systems research.

March 9, 2011
Lilly head continues call for medical innovation

Eli Lilly leader John Lechleiter has become something of an evangelist for medical innovation lately. On Wednesday, the Lilly chairman, president and CEO spoke to the U.S./Japan Business Council in Tokyo to call for changes and policies in the biopharmaceutical industry that encourage innovation, or “reinventing invention,” as he called it.

February 18, 2011
As innovaters prep for patent cliff, generics prosper from patent losses

A whole slew of drugs will lose patent protection this year, opening up opportunities for generic drug makers to market their own versions. Most notable among these is Pfizer’s cholesterol-
lowering drug Lipitor (atorvastatin), the world’s top-selling drug, with U.S. sales of $7 billion during the 12 months ended September 2010, according to IMS Health.


February 14, 2011
Lilly appoints new oncology unit president

Following the exit of its oncology unit leader, drug maker Eli Lilly announced two executive changes.

February 10, 2011
Lilly chief calls on industry, public policy to support innovation

Public policies to support medical innovation will help drug companies address diseases that devastate people’s lives, a drug company executive said at a summit Thursday.

February 3, 2011
Lilly, JDRF enter research agreement

Drug maker Eli Lilly and the Juvenile Diabetes Research Foundation will fund research to find ways to regenerate insulin-producing cells in patients with Type 1 diabetes.

February 2, 2011
Decision Resources: Bydureon could promote weight loss among patients

Eli Lilly’s and Amylin Pharmaceuticals’ Type 2 diabetes drug, Bydureon, appears to work better at promoting weight loss than drugs made by Takeda and Merck, but it could face a challenger of its own.

January 25, 2011
Head of Lilly's oncology biz resigns

John Johnson is bidding Eli Lilly adieu.

January 17, 2011
FDA panel votes against Lilly's EPI treatment

A Food and Drug Administration advisory committee voted last week not to recommend approval of a drug from Eli Lilly.

January 11, 2011
BI, Lilly form strategic partnership for diabetes drugs

U.S. drug maker Eli Lilly and German drug maker Boehringer Ingelheim will collaborate to develop drugs for diabetes, the companies said Tuesday.

December 21, 2010
Lilly completes acquisition of Avid

One month after announcing it would acquire a leader in molecular imaging development, Eli Lilly announced it has completed its acquisition of Avid Radiopharmaceuticals.

December 20, 2010
Lilly donates grant to Manchester College for pharmacy school

Manchester College has received a $35 million grant from the Lilly Endowment to launch a new school of pharmacy.

December 14, 2010
Citing safety concerns, Lilly suspends cancer drug trial

Eli Lilly is suspending a late-stage clinical trial of a cancer drug amid safety concerns, the drug maker said Monday.

December 9, 2010
Combining Lilly and Amylin drug with insulin intake found to promote weight loss

Combining a diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals controls blood sugar and promotes weight loss more than insulin alone, according to a new study.

November 24, 2010
FDA approves Axiron

Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.

November 17, 2010
Byetta may cut cardiovascular risk for diabetes patients

A Type 2 diabetes drug marketed by Eli Lilly and Amylin Pharmaceuticals may lower the...

November 15, 2010
Generic versions of Alimta, Abilify get shut down by district courts

The U.S. District Court for the District of Delaware has upheld a patent held by...

© 2013 Drug Store News. All Rights Reserved.